Hemex Health

03/19/2026

At the 1st National Day of Pooling of Hyperspecialty Resources(1ère Journée Nationale des Mutualisations des hyperspecialités) in DR Congo, with over 250 delegates in attendance. It was all about resource mobilisation in addressing in Congo. A bold step in combatting neglected disease areas of concerns within most vanorable populace in our societies.

drives both , and diagnostic interventions that speaks to the hearts and minds of healthcare professionals addressing challenges faced within a disenfranchised and care settings. The importance of early diagnosis of anemia, continuous monitoring of deficiency as well as early diagnosis of is the cornerstone of electrophoresis by Hemex Health, Inc. In both urban and rural setting, speaking to right to quality healthcare for all. Thanks to our partners in DRC for engaging stakeholders on such important solutions to market.

03/12/2026

To effectively address challenges of and it’s impact in the society in Africa. There has to be collective responsibility and effective political good will. This will ensure placing disease burned at the right level of action as well as effective resources Mobility.

Congratulations to MoH Uganda- Department of National Health Laboratory and Diagnostic Services(NHLDS) Parliament of Uganda for taking the first step forward in the continent. I thank our partner NICOSAM HEALTHCARE LTD and other stakeholders who have put their skin in the game.
We continue to advance critical provision of care in diagnostic using HB electrophoresis an innovative technology from Hemex Health, Inc.
Terumo Blood and Cell Technologies David Obluk Gerrit J. van Roekel Patti White

03/08/2026

This International Women’s Day, the theme reminds us that when we invest in women, everyone benefits. By providing support, opportunity, and access, we build stronger communities, healthier families, and more resilient health systems.

Today, we celebrate the women advancing healthcare — delivering care, driving research, leading innovation, and championing better outcomes around the world.

02/28/2026

As Rare Disease Day approaches, Hemex Health, Inc. stands with the global rare disease community and with sickle cell warriors and their families. While sickle cell disease affects approximately 100,000 individuals in the United States, it impacts millions worldwide. Raising awareness is only part of the mission - improving outcomes depends on expanding access to early, accurate diagnosis. Bridging the gap requires decentralized, affordable testing solutions that reach patients wherever they live.

02/13/2026

Black History Month is a time to recognize the Black leaders and communities who have driven awareness and progress in sickle cell care.

We’re committed to expanding access to early, accurate diagnosis — because timely answers matter.

12/05/2025

✨ We’re Heading to ASH 2025! ✨
We’re excited to share that our team will be at ASH 2025 with multiple poster presentations highlighting advances in sickle cell disease diagnostics, point-of-care testing, and global health impact.

We look forward to seeing you at !


whitepdx .peter

12/05/2025

Hear the results of a study conducted at Brown University to study the effectiveness of the Gazelle Ferritin FIA test to identify iron deficiency (ID) at point-of-care.

The presentation by Vivian Uzoechi, MPH, is part of session 901: Closing the Quality Gap, Women’s Health and Rapid Testing.

11/26/2025

Today, on Iron Deficiency Day, we’re raising awareness about the importance of ferritin testing and early intervention.

Here at , Inc., we’re committed to bringing critical blood-health diagnostics closer to the people who need them most.

11/20/2025

Honored to receive the Growth Stage Award from the Oregon Entrepreneurs Network! 🎉

We appreciate OEN's commitment to fostering connections and support for innovative startups in Oregon.

Thank you to Cara Turano and team for putting together an amazing event and to Patti White, Peter Galen, and J Daren Bledsoe for your leadership.

Also pictured:
Stephanie B. & Hannah Steinbach

10/16/2025

October is Global Diversity Awareness Month — a time to celebrate the communities around the world and to remind us that health matters everywhere. 🌎

At Hemex Health, we recognize that sickle cell disease and beta thalassemia affect people of many backgrounds.

We stand with advocacy groups around the world working to expand awareness, increase access to testing, and encourage early detection for all.
Through Gazelle®*, we’re proud to support accessible, accurate testing for communities everywhere. 💙

*Not for sale in the U.S.

09/22/2025

🩸 Despite being one of the most common genetic conditions worldwide (WHO), sickle cell disease remains a neglected global health burden, receiving less attention and fewer resources than warranted by its prevalence (NIH, WHO).

🔬We proudly stand with and advocacy groups globally to raise awareness for the continued need to address this disease. Gazelle supports initiatives in early screening and testing worldwide.

Learn more:
WHO - https://www.who.int/news-room/fact-sheets/detail/sickle-cell-disease
NIH - https://www.nhlbi.nih.gov/health/sickle-cell-disease

*Hemex Health products are not available in all markets, including the U.S.

09/09/2025